Oncology & Cancer

Adding rituximab to chemo ups event-free survival in ALL

(HealthDay)—For young adults with acute lymphoblastic leukemia (ALL), adding rituximab to chemotherapy is associated with increased event-free survival, according to a study published in the Sept. 15 issue of the New England ...

page 5 from 6